TA-3166 (Megakaryocytes/platelets inducing agent) is a novel chemically synthesized c-MPL agonist (CMA) and thrombopoietin (TPO) receptor agonist. TA-316 enhances ex vivo platelet generation from human-induced pluripotent stem (iPS) cells.
体外研究
TA-316 (0.01-1000 nM; 4 days) stimulates UT-7/TPO and Ba/F3-HuMpl cells proliferation, with the EC50 values of 0.3 and 0.65 nM, respectively.
TA-316 (800 nM; 10 days) promotes biased megakaryopoiesis and upregulated MK lineage markers.
TA-316 (200 nM; 4 days) preferentially enhances VEGFA and FGF2 expression.
Cell Viability Assay
Cell Line:
UT-7/TPO and Ba/F3-HuMpl cells
Concentration:
0.01-1000 nM
Incubation Time:
4 days
Result:
Stimulated UT-7/TPO and Ba/F3-HuMpl cell proliferation.
分子式
C28H25BrN4O5S2
分子量
641.56
CAS号
1429321-13-0
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder
-20°C
3 years
4°C
2 years
In solvent
-80°C
6 months
-20°C
1 month
溶解性数据
In Vitro:
DMSO : 50 mg/mL (77.94 mM; ultrasonic and warming and heat to 60°C)